Christopher Horan - Feb 26, 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Chief Tech Operations Officer
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
Stock symbol
ARTV
Transactions as of
Feb 26, 2025
Transactions value $
$0
Form type
4
Date filed
2/28/2025, 05:15 PM
Previous filing
Sep 13, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARTV Common Stock Award $0 +60K +240% $0.00 85K Feb 26, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.